Ubiquigent Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $936K
Latest Deal Amount
  • Investors
  • 6

Ubiquigent General Information


Provider of drug discovery services intended to offer tools, reagents, kits, and other biological products for the drug development process. The company's services are based on cell-signalling system for the development and optimization of drug candidate compounds that target the system addressing a number of critical therapeutic areas, enabling academic and pharmaceutical researchers to understand the role of protein ubiquitylation in regulating many aspects of cellular functions and to accelerate in the drug discovery arena.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Sir James Black Centre
  • Dow Street
  • Dundee DD1 5EH
  • Scotland, United Kingdom
+44 01382 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ubiquigent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 15-Aug-2018 $936K 00.000 00.000 Completed Generating Revenue
3. Grant 19-Jan-2017 00000 Completed Generating Revenue
2. Seed Round 18-Sep-2013 $783K $783K 00.000 Completed Generating Revenue
1. Corporate 03-Mar-2010 Completed Generating Revenue
To view Ubiquigent’s complete valuation and funding history, request access »

Ubiquigent Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Ubiquigent’s complete cap table history, request access »

Ubiquigent Executive Team (3)

Name Title Board Seat Contact Info
Jason Mundin Board Member & Managing Director
You’re viewing 1 of 3 executive team members. Get the full list »

Ubiquigent Board Members (7)

Name Representing Role Since
Ian Ratcliffe Self Board Member 000 0000
Jason Mundin Ubiquigent Board Member & Managing Director 000 0000
Jonathan Treherne Ph.D Ubiquigent Co-Chairman 000 0000
Laurence Ede Ubiquigent Board Member 000 0000
Mark Treherne Ph.D Self Co-Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Ubiquigent Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ubiquigent Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
Medical Research Council Corporation Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
University of Dundee Endowment Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »